Integrated offering to be provided by new dedicated service group under PAREXELreg; AccessBOSTON, September 6, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has launched a new end-to-end service offering to provide real-world data insights that help life science companies more effectively demonstrate product value. “In an increasingly competitive market, leveraging data to demonstrate value is critical. However, unstructured data can make it difficult to overcome…

Source: RealWire

Leave a Reply